Analysis of over‐the‐counter products marketed to treat molluscum contagiosum

Many over‐the‐counter (OTC) products are marketed to treat molluscum contagiosum, a common childhood viral infection with an estimated point prevalence of 5%‐11%. As optimal treatment has not been defined, a comprehensive internet search was performed to identify OTC products marketed for treating m...

Full description

Saved in:
Bibliographic Details
Published in:Pediatric dermatology 2021-09, Vol.38 (5), p.1400-1403
Main Authors: Ong, Samantha K., Hoft, Isaac, Siegfried, Elaine
Format: Article
Language:English
Subjects:
Biological products
Children
Dosage
Flowers & plants
molluscum
Molluscum contagiosum
Nonprescription drugs
over‐the‐counter
Pediatrics
Pruritus
Skin diseases
Thuja
Topical medication
treatment
Viral infections
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Many over‐the‐counter (OTC) products are marketed to treat molluscum contagiosum, a common childhood viral infection with an estimated point prevalence of 5%‐11%. As optimal treatment has not been defined, a comprehensive internet search was performed to identify OTC products marketed for treating molluscum and to collect information on packaging, ingredients, application instructions, and dosing. Nine OTC products were identified and varied widely in cost, packaging size, and ingredients; six of the nine products contained Thuja occidentalis. Overall, the majority of OTC package labels do not include sufficient information about their plant‐based ingredients or appropriate dosing.
ISSN:0736-8046
1525-1470
DOI:10.1111/pde.14776